Fig. 1From: Mesenchymal stem cells decrease lung inflammation during sepsis, acting through inhibition of the MAPK pathwayMice treated with MSCs showed a reduced inflammation score in the lung. a Lung sections were subjected to H&E staining. b The inflammatory cells that infiltrated into the peribronchial and perivascular lung tissues in the sepsis group were ameliorated after MSC administration (×200 magnification). Data represent the mean ± SEM, n = 5. ### p < 0.001, sham versus sepsis group; ***p < 0.001, sepsis versus sepsis + MSC group. LPS lipopolysaccharide; MSC mesenchymal stem cellBack to article page